Integrated Diagnostics Holdings plc
IDGXF
$0.64
$0.046.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.50% | 2.97% | 55.63% | -13.28% | -9.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.50% | 2.97% | 55.63% | -13.28% | -9.92% |
| Cost of Revenue | 25.16% | -5.89% | 48.39% | -12.63% | -13.47% |
| Gross Profit | 63.46% | 18.32% | 68.38% | -14.23% | -3.27% |
| SG&A Expenses | 10.89% | 0.22% | 223.82% | -36.72% | -2.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -172.34% | -375.90% | -3,739.38% | -- | -113.26% |
| Total Operating Expenses | 20.12% | -5.79% | 45.75% | -18.04% | -13.21% |
| Operating Income | 139.88% | 40.77% | 98.08% | 1.48% | 12.18% |
| Income Before Tax | 164.38% | -38.21% | 328.74% | -43.43% | 21.07% |
| Income Tax Expenses | 69.27% | 14.87% | 272.23% | -- | 22.33% |
| Earnings from Continuing Operations | 292.90% | -51.60% | 379.25% | -11.91% | 19.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -154.58% | -142.45% | 53.77% | -- | 179.57% |
| Net Income | 156.19% | -55.08% | 295.51% | -12.59% | 44.74% |
| EBIT | 139.88% | 40.77% | 98.08% | 1.48% | 12.18% |
| EBITDA | 99.87% | 25.67% | 65.63% | -2.60% | 3.51% |
| EPS Basic | 160.00% | -53.47% | 306.78% | -9.38% | 48.15% |
| Normalized Basic EPS | 89.09% | -41.25% | 254.79% | -- | 44.74% |
| EPS Diluted | 160.00% | -53.47% | 306.78% | -9.38% | 48.15% |
| Normalized Diluted EPS | 89.09% | -41.25% | 254.79% | -- | 44.74% |
| Average Basic Shares Outstanding | -3.11% | -3.11% | -3.11% | -3.11% | 0.00% |
| Average Diluted Shares Outstanding | -3.11% | -3.11% | -3.11% | -3.11% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |